US HB4619 | 2019-2020 | 116th Congress

Status

Spectrum: Partisan Bill (Democrat 3-0)
Status: Introduced on October 8 2019 - 25% progression, died in committee
Action: 2019-10-09 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Requires drug manufacturers, subject to civil penalties, to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under the Medicare prescription drug benefit that cost $100 or more and for which the average manufacturer price increases faster than inflation.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Pharmaceutical REPAI Act Pharmaceutical Rebates for Excessive Pricing Above Inflation Act

Sponsors


History

DateChamberAction
2019-10-09HouseReferred to the Subcommittee on Health.
2019-10-08HouseReferred to the Subcommittee on Health.
2019-10-08HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-10-08HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-10-08HouseIntroduced in House

Same As/Similar To

HB3 (Related) 2020-09-08 - Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 521.
HR758 (Similar To) 2019-12-11 - Mr. Nadler moved to table the motion to reconsider

Subjects


US Congress State Sources


Bill Comments

feedback